Clinical Trial Update: Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of sirolimus in tuberous sclerosis complex and lymphangioleiomyomatosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis
• Tuberous Sclerosis Complex

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Cardiff University | Conditions: Tuberous Sclerosis, Lymphangioleiomyomatosis | Phase 2 | Status: UNKNOWN